GABA system changes in methylphenidate sensitized female rats

Behavioural Brain Research

Volumn 231, Issue 1, 2012, Pages 181-186

  Freese, L ^a   Muller, E J ^a   Souza, M F ^a   Couto Pereira, N S ^a   Tosca, C F ^a   Ferigolo, M ^a   Barros, H M T ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; MESSENGER RNA; METHYLPHENIDATE; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG SENSITIZATION; FEMALE; GABAERGIC SYSTEM; LOCOMOTION; NONHUMAN; OVARIECTOMY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM SENSITIZATION; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; METHYLPHENIDATE; MOTOR ACTIVITY; NEURONS; OVARIECTOMY; RATS;

EID: 84859387837     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.03.017     Document Type: Article

References (46)

1. Faraone S.V., Spencer T., Aleardi M., Pagano C., Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attentional-deficit/hyperactivity disorder. J Clin Psychopharmacol 2004, 24:24-29.
2. Sweetman S.C. Methylphenidate hydrochloride. Martindale: the complete drug reference 2009, 2159-2160. Pharmaceutical Press, London. thirty-sixth ed. S.C. Sweetman (Ed.).
3. Yang P., Beasley A., Eckermann K., Swann A., Dafny N. Valproate modulates the expression of methylphenidate (Ritalin) sensitization. Brain Res 2000, 874:216-220.
4. Wu L.T., Pilowsky D.J., Schlenger W.E., Galvin D.M. Misuse of methamphetamine and prescription stimulants among youths and young adults in the community. Drug Alcohol Depend 2007, 89:195-205.
5. Teter C., McCabe S.E., LaGrange K., Cranford J.A., Boyd C.J. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006, 26:1501-1510.
6. Volkow N.D., Fowler J.S., Wang G.J., Ding Y.S., Gatley S.J. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur Neuropsychopharmacol 2002, 2:557-566.
7. Swanson J.M., Volkow N.D. Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev 2003, 27:615-621.
8. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995, 52:456-463.
9. Yano M., Steiner H. Methylphenidate and cocaine: the same effects on gene regulations. Trends Pharmacol Sci 2007, 11:588-596.
10. Volkow N.D., Wang G., Fowler J.S., Logan J., Gerasimo V.M., Maynard L., et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001, 21:RC121.
11. Gatley S.J., Volkow N.D., Gifford A.N., Fowler J.S., Dewey S.L., Ding Y.S., et al. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology (Berl) 1999, 146:93-100.
12. Kollins S.H., MacDonald E.K., Rush C.R. Assessing the abuse potential of methylphenidate in nonhuman and human subjects. A review. Pharmacol Biochem Behav 2001, 68:611-627.
13. Volkow N.D., Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 2003, 160:1909-1918.
14. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 1997, 25:192-216.
15. Kalivas P.W., O'brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008, 33:166-180.
16. Gaytan O., al-Rahim S., Swann A., Dafny N. Sensitization to locomotor effects of methylphenidate in the rat. Life Sci 1997, 61:101-107.
17. Yang P., Beasley A., Eckermann K., Swann A., Dafny N. Valproate prevents the induction of sensitization to methylphenidate (Ritalin) in rats. Brain Res 2000, 887:276-284.
18. Yang P.B., Swann A.C., Dafny N. Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization. Brain Res 2007, 1145:66-80.
19. Robinson T.E., Berridge K.C. Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B: Biol Sci 2008, 363:3137-3146.
20. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000, 51:99-120.
21. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 1991, 16:223-244.
22. Hu M., Becker J.B. Effects of sex and estrogen on behavioral sensitization to cocaine in rats. J Neurosci 2003, 23:693-699.
23. Segarra A.C., Rivera A.J.L., Febo M., Escobar N.L., Delmestre R.M., Ramos A.P. Estradiol: a key biological substrate mediating the response to cocaine in female rats. Horm Behav 2009, 58:33-43.
24. Dafny N., Yang P.B. The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res Bull 2006, 68:393-405.
25. Souza M.F., Toniazo V.M., Frazzon A.P., Barros H.M. Influence of progesterone on GAD65 and GAD67 mRNA expression in the dorsolateral striatum and prefrontal cortex of female rats repeatedly treated with cocaine. Braz J Med Biol Res 2009, 42:1068-1075.
26. Caruncho H.J., Liste I., Rozas G., López-Martín E., Guerra M.J., Labandeira-García J.L. Time course of striatal, pallidal and thalamic alpha 1, alpha 2 and beta 2/3 GABAA receptor subunit changes induced by unilateral 6-OHDA lesion of the nigrostriatal pathway. Brain Res Mol Brain Res 1997, 48:243-250.
27. Kuczenski R., Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 2001, 296:876-883.
28. Leonard B.E., Mccartan D., White J., King D.J. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 2004, 19:151-180.
29. Marcondes F.K., Bianchi F.J., Tanno A.P. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 2002, 62(4A):609-614.
30. Peris J., Decambre N., Coleman-Hardee M.L., Simpkins J.W. Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release. Brain Res 1991, 566:255-264.
31. Zhou W., Cunningham K.A., Thomas M.L. Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Brain Res Mol Brain 2002, 100:75-83.
32. Lynch W.J. Sex differences in vulnerability to drug self-administration. Exp Clin Psychopharmacol 2006, 14:34-41.
33. Greenfield S.F., Back S.E., Lawson K., Brady K.T. Substance abuse in women. Psychiatr Clin N Am 2010, 32:339-355.
34. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 1998, 54:679-720.
35. Agmo A., Belzung C., Giordano M. Interactions between dopamine and GABA in the control of ambulatory activity. J Neural Transm 1996, 103:925-934.
36. Lindefors N., Hurd Y.L., O'Connor W.T., Brene S., Persson H., Ungerstedt U. Amphetamine regulation of acetylcholine and gamma-aminobutyric acid in nucleus accumbens. Neuroscience 1992, 48:439-448.
37. Jayaram P., Steketee J.D. Effects of cocaine-induced behavioral sensitization on GABA transmission within rat medial prefrontal cortex. Eur J Neurosci 2005, 21:2035-2039.
38. Soghomonian J.J., Martin D.L. Two isoforms of glutamate decarboxylase: why. Trends Pharmacol Sci 1998, 19:500-505.
39. Tian N., Petersen C., Kash S., Baekkeskov S., Copenhagen D., Nicoll R. The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc Natl Acad Sci U S A 1999, 96:12911-12916.
40. Sorg B.A., Guminski B.J., Hooks M.S., Kalivas P.W. Cocaine alters glutamic acid decarboxylase differentially in the nucleus accumbens core and shell. Brain Res Mol Brain Res 1995, 29:381-386.
41. Dixon C.I., Morris H.V., Breen G., Desrivieres S., Jugurnauth S., Steiner R.C. Cocaine effects on mouse incentive-learning and human addiction are linked to alpha2 subunit-containing GABAA receptors. Proc Natl Acad Sci U S A 2010, 107:2289-2294.
42. Zhang X., Lee T.H., Xiong X., Chen Q., Davidson C., Wetsel W.C., et al. Methamphetamine induces long-term changes in GABAA receptor alpha2 subunit and GAD67 methylphenidate enantiomers: does chirality matter. Biochem Biophys Res Commun 2008, 28:S54-S61.
43. Nelson P.T., Keller J.N. RNA in brain disease: no longer just the messenger in the middle. J Neuropathol Exp Neurol 2007, 66:461-468.
44. McEwen B.S. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 2001, 91:2785-2801.
45. Porter T.G., Martin D.L. Evidence for feedback regulation of glutamate decarboxylase by gamma-aminobutyric acid. J Neurochem 1984, 43:1464-1467.
46. Robinson T.E., Berridge K.C. Mechanisms of action of addictive stimuli: incentive-sensitization and addiction. Addiction 2001, 96:103-114.